Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 19/20 | 0.63 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.60 |
| ▸ | PDE4A | P27815 | 11/20 | 0.59 |
| ▸ | PDE4B | Q07343 | 11/20 | 0.59 |
| ▸ | PDE4C | Q08493 | 11/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2886875 | 1.00 | PDE4D (0.63) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| Hydrochloric Acid SCHEMBL4011677 | 0.99 | PDE4D (0.62) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL2887808 | 0.90 | PDE7B (0.73) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL5528256 | 0.90 | PDE7B (0.73) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL2889850 | 0.88 | PDE4D (0.60) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL5875839 | 0.88 | PDE4D (0.60) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| Hydrochloric Acid SCHEMBL4357313 | 0.88 | PDE4D (0.59) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL2886831 | 0.87 | PDE4D (0.74) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL6467291 | 0.87 | PDE4D (0.74) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL4011641 | 0.87 | PDE4D (0.63) | PDE4DPDE7BPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2006528229-A | — | — | 2006-12-14 | — | — | JP | claimed |
| EP-1628682-A2 | COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR | ALTANA Pharma AG (DE) | 2006-03-01 | — | — | EP | claimed |
| EP-1587512-A2 | PDE4 INHIBITORS FOR THE TREATMENT OF NEOPLASMS OF LYMPHOID CELLS | ALTANA Pharma AG (DE) | 2005-10-26 | — | — | EP | claimed |
| WO-2004103407-A2 | COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR | ALTANA PHARMA AG (DE) | 2004-12-02 | — | — | WO | claimed |
| WO-2004098633-A1 | COMPOSITION COMPRISING A PDE-4 INHIBITOR AND A TNF ALPHA ANTAGONIST | ALTANA PHARMA AG (DE) | 2004-11-18 | — | — | WO | claimed |
| WO-2004098606-A1 | COMPOSITION COMPRISING A PDE4 INHIBITOR AND SHUIL-1R II | ALTANA PHARMA AG (DE) | 2004-11-18 | — | — | WO | claimed |
| WO-2004062671-A2 | PDE4 INHIBITORS FOR THE TREATMENT OF NEOPLASMS OF LYMPHOID CELLS | ALTANA PHARMA AG (DE) | 2004-07-29 | — | — | WO | claimed |
| EP-1628682-A2 | COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR | ALTANA Pharma AG (DE) | 2006-03-01 | — | — | EP | disclosed |
| EP-1587512-A2 | PDE4 INHIBITORS FOR THE TREATMENT OF NEOPLASMS OF LYMPHOID CELLS | ALTANA Pharma AG (DE) | 2005-10-26 | — | — | EP | disclosed |
| EP-1482938-A1 | PHARMACEUTICAL COMPOSITION OF A PDE4 OR A PDE3/4 INHIBITOR AND A HISTAMINE RECEPTOR ANTAGONIST | ALTANA Pharma AG (DE) | 2004-12-08 | — | — | EP | disclosed |
| WO-2004103407-A2 | COMPOSITION COMPRISING A PDE4 INHIBITOR AND A PDE5 INHIBITOR | ALTANA PHARMA AG (DE) | 2004-12-02 | — | — | WO | disclosed |
| WO-2004098605-A1 | PHARMACEUTICAL COMPOSITION COMPRISING A PDE4 INHIBITOR AND IL-1 TRAP | ALTANA PHARMA AG (DE) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004098606-A1 | COMPOSITION COMPRISING A PDE4 INHIBITOR AND SHUIL-1R II | ALTANA PHARMA AG (DE) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004098578-A2 | COMPOSITION COMPRISING A PDE4 INHIBITOR AND A TNF-ALFA ANTAGONIST SELECTED FROM INFLIXIMAB, ADALIMUMAB, CDP870 AND CDP517 | ALTANA PHARMA AG (DE) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004062671-A2 | PDE4 INHIBITORS FOR THE TREATMENT OF NEOPLASMS OF LYMPHOID CELLS | ALTANA PHARMA AG (DE) | 2004-07-29 | — | — | WO | disclosed |
| WO-2003074055-A1 | PHARMACEUTICAL COMPOSITION OF A PDE4 OR A PDE3/4 INHIBITOR AND A HISTAMINE RECEPTOR ANTAGONIST | ALTANA PHARMA AG (DE) | 2003-09-12 | — | — | WO | disclosed |